StockTipsArenaBeta

BUY Caplin Point Laboratories Limited — Rajesh Palviya, Axis Securities

BUYCaplin Point Laboratories Limited
Caplin Point Laboratories share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))2 Sept 2026via ET Now (Live)

Entry₹2,710Inferred
Target₹2,850
Total upside +5.17% (call closed)
Stop loss₹2,650-2.21% risk
Exit₹2,8503 Sept 2026, 10:45 am
Target hit+5.17%0.00%upside left
Follow Rajesh Palviya for new calls(27% target hit, 178 closed calls)Get alertsWatch CAPLIPOINT for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 3 Sept 2026
2 supporting0 opposing
Supports the BUY call (2)

Caplin Point Subsidiary Gets Colombian GMP Certification

NewsGoogle News·1 Sept · yesterday

(opens in new tab)

Caplin Steriles Gets 10 USFDA Observations at Gummidipoondi Facility

NewsGoogle News·22 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Caplin Point Laboratories

All analyst calls on Caplin Point Laboratories

More from Rajesh Palviya, Axis Securities

Every call and its outcome